Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A
Malignant neoplasm of colon and/or rectum
0.100 AlteredExpression BEFREE The diagnostic sensitivity, specificity and accordance rates of positive miR-27a and miR-31 expression in colorectal cancer were recorded. 31452786

2019

Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A
Malignant neoplasm of colon and/or rectum
0.100 Biomarker BEFREE Patients with colorectal cancer with high expression of circulating exosomal miR-27a or miR-130a underwent poorer prognosis.<b>Conclusions:</b> We identified a circulating exosomal miRNAs panel for the detection of colorectal cancer.<b>Impact:</b> The exosomal miR-27a and miR-130a panel in plasma may act as a noninvasive biomarker for early detection and predicting prognosis of colorectal cancer. 29739748

2018

Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A
Malignant neoplasm of colon and/or rectum
0.100 Biomarker BEFREE miR-27a-3p targeting RXRα promotes colorectal cancer progression by activating Wnt/β-catenin pathway. 29137318

2017

Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A
Malignant neoplasm of colon and/or rectum
0.100 Biomarker BEFREE Knockdown of microRNA-27a resensitized colorectal cancer stem cells to TRAIL-induced cell death. 28423356

2017

Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A
Malignant neoplasm of colon and/or rectum
0.100 Biomarker BEFREE miR‑27a promotes proliferation, migration, and invasion of colorectal cancer by targeting FAM172A and acts as a diagnostic and prognostic biomarker. 28440497

2017

Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A
Malignant neoplasm of colon and/or rectum
0.100 GeneticVariation BEFREE Association between microRNA-27a rs895819 polymorphism and risk of colorectal cancer: A meta-analysis. 27751356

2016

Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A
Malignant neoplasm of colon and/or rectum
0.100 Biomarker BEFREE Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer. 26913609

2016

Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A
Malignant neoplasm of colon and/or rectum
0.100 GeneticVariation BEFREE Genotype GG of rs895819 Functional Polymorphism Within miR-27a Might Increase Genetic Susceptibility to Colorectal Cancer in Han Chinese Population. 26302683

2016

Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A
Malignant neoplasm of colon and/or rectum
0.100 AlteredExpression BEFREE The overexpression of miR-27a in the human colorectal cancer cell line HCT-116<sup>+/+</sup> resulted in the decreased expression of the endogenous p53 protein levels. 27531966

2016

Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A
Malignant neoplasm of colon and/or rectum
0.100 Biomarker BEFREE Novel Evidence for Curcumin and Boswellic Acid-Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer. 25712055

2015

Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A
Malignant neoplasm of colon and/or rectum
0.100 GeneticVariation BEFREE Association between miR-27a genetic variants and susceptibility to colorectal cancer. 25078482

2014

Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A
Malignant neoplasm of colon and/or rectum
0.100 GeneticVariation BEFREE Association between a functional variant in microRNA-27a and susceptibility to colorectal cancer in a Chinese Han population. 25222241

2014

Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A
Malignant neoplasm of colon and/or rectum
0.100 Biomarker BEFREE Therefore, miR-27a could be a useful biomarker for monitoring colorectal cancer development and progression, and also could have a therapeutic potential by targeting SGPP1, Smad2 and STAT3 for colorectal cancer therapy. 25166914

2014

Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A
Malignant neoplasm of colon and/or rectum
0.100 GeneticVariation BEFREE Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. 22719192

2012

Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A
Malignant neoplasm of colon and/or rectum
0.100 Biomarker BEFREE The FCS method had a significant advantage over miRNA differential expression analysis when identifying cancer-related miRNAs with a fine regulatory mechanism, such as miR-27a in colorectal cancer. 21976726

2011